Latest Operating Expenses News

Page 9 of 106
Frontier Digital Ventures has shrunk its top line by 27% as it exits low-margin businesses, but the reset delivered higher EBITDA, a 17% margin and near-total free cash flow conversion in the first half of FY2026. The next test is whether pricing and cost discipline can lift earnings without further customer erosion.
Victor Sage
Victor Sage
23 Sept 2026
Rua Bioscience delivered a sharp rise in customer revenue and secured a UK agreement expected to generate NZ$10 million over two years. But PwC disclaimed an audit opinion, warning the company may not have enough cash without another capital raise.
Ada Torres
Ada Torres
22 Sept 2026
Vectus Biosystems swung to a $1.56 million FY2026 profit, but the result was driven largely by the sale of its VB4-P5 compound for XORTX shares and warrants rather than recurring operations. The company is now directing its resources towards VB0004 while its auditor flags material uncertainty over ongoing funding.
Ada Torres
Ada Torres
18 Sept 2026
Dataworks Group has lodged a prospectus for a non-renounceable entitlement offer targeting A$1.24 million, alongside a committed A$3 million placement. The raising would fund debt repayment, working capital and contract mobilisation, but also materially expand the company’s share count and option pool.
Sophie Babbage
Sophie Babbage
18 Sept 2026
JPMorgan Equity Premium Income ETF reported a sharp fall in operating profit as fair-value losses overwhelmed higher distribution income. The fund will also switch its underlying ETF from NYSE Arca to a London-listed vehicle, while keeping its stated investment objective and total management fees and costs unchanged.
Claire Turing
Claire Turing
15 Sept 2026
JPMorgan Global Select Equity Fund reported A$39.1 million in operating profit for the year ended 30 June 2026, with net assets rising to A$578.3 million. The result includes fair value gains and comes with a concentrated portfolio, with 100% of fair value investments tied to the underlying JPMorgan Global Select Equity ETF.
Victor Sage
Victor Sage
14 Sept 2026
JPMorgan Global Research Enhanced Index Equity Trust (ASX:JRH) reported a sharp rise in FY2026 operating profit, driven primarily by investment revaluation gains as net assets expanded to almost A$2 billion. Distributions also surged, although the result remains exposed to global equity markets, foreign exchange and derivatives.
Claire Turing
Claire Turing
14 Sept 2026
JPMorgan Global Research Enhanced Index Equity Trust reported a sharp rise in operating profit and net assets for the year ended 30 June 2026, powered largely by fair value gains across its global portfolio. Distributions also increased substantially, particularly for hedged classes, although the report does not show whether the Fund outperformed its benchmark.
Victor Sage
Victor Sage
14 Sept 2026
Pacific Edge is positioning Cxbladder for a Medicare-led recovery, but the company remains loss-making with NZ$7.8 million in net cash after a difficult FY26. The investment case now turns on final US coverage, test volumes and whether the enlarged balance sheet can carry the business to scale.
Ada Torres
Ada Torres
14 Sept 2026
Kingfish’s adjusted NAV rose 1.2% in August, broadly matching the NZX benchmark as Vista, Fisher & Paykel Healthcare and Delegat delivered the strongest portfolio gains. The fund still trades at a 7.5% discount to NAV, while its one-year shareholder return remains negative.
Claire Turing
Claire Turing
11 Sept 2026
Way2VAT has secured binding commitments for a A$2.109 million placement, giving the fintech capital to fund the next RBC acquisition payment and its e-invoicing expansion. The raise comes at a 29% discount and carries potential further dilution through free-attaching options.
Victor Sage
Victor Sage
9 Sept 2026
Iondrive Limited’s updated evaluation of its IONSolv™ technology projects a US$243 million post-tax NPV and US$62 million annual EBITDA for a single rare earth recovery module in the US, driven by high feedstock grade assumptions and independently validated recoveries.
Maxwell Dee
Maxwell Dee
7 Sept 2026

Browse the archive

Full archive